The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD. 1978

J A Rosecrans, and W T Chance, and R M Spencer

Rats learned to discriminate cyclazocine (2 mg/kg, i.p.) from saline using a two-lever operant (FR-4) procedure within 10 sessions under each drug condition. The cyclazocine discriminative stimulus (DS) was both dose- and time-related, being antagonized by naloxone at doses approximately 80 times that necessary to block the discriminative stimulus effect of morphine. Cyclazocine also generalized to nalorphine, but not to morphine, pentazocine or LSD. These data suggest that cyclazocine produced DS control of behavior by acting at CNS sites different from those affected by morphine or LSD.

UI MeSH Term Description Entries
D008238 Lysergic Acid Diethylamide Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood. LSD,Lysergide,LSD-25,Lysergic Acid Diethylamide Tartrate,Acid Diethylamide, Lysergic,Diethylamide, Lysergic Acid,LSD 25
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009269 Nalorphine A narcotic antagonist with some agonist properties. It is an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. Given alone it produces a broad spectrum of unpleasant effects and it is considered to be clinically obsolete. Allylnormorphine,Lethidrone,Nalorphine Hydrobromide,Nalorphine Hydrochloride,Nalorphine, (14 alpha)-Isomer,Nalorphine, L-tartrate (1:1),Hydrobromide, Nalorphine,Hydrochloride, Nalorphine
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D003496 Cyclazocine An analgesic with mixed narcotic agonist-antagonist properties.
D004192 Discrimination, Psychological Differential response to different stimuli. Discrimination, Psychology,Psychological Discrimination
D005793 Generalization, Psychological The phenomenon of an organism's responding to all situations similar to one in which it has been conditioned. Generalization (Psychology),Generalization, Psychology,Generalizations (Psychology),Generalizations, Psychological,Generalizations, Psychology,Psychological Generalization,Psychological Generalizations,Psychology Generalization,Psychology Generalizations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J A Rosecrans, and W T Chance, and R M Spencer
November 1977, Psychopharmacology,
J A Rosecrans, and W T Chance, and R M Spencer
December 1983, The Journal of pharmacology and experimental therapeutics,
J A Rosecrans, and W T Chance, and R M Spencer
May 1976, Psychopharmacology,
J A Rosecrans, and W T Chance, and R M Spencer
January 1978, Neuropharmacology,
J A Rosecrans, and W T Chance, and R M Spencer
January 1984, Psychopharmacology,
J A Rosecrans, and W T Chance, and R M Spencer
September 1976, Neuropharmacology,
J A Rosecrans, and W T Chance, and R M Spencer
March 1980, The Journal of pharmacology and experimental therapeutics,
J A Rosecrans, and W T Chance, and R M Spencer
March 1967, International journal of neuropharmacology,
J A Rosecrans, and W T Chance, and R M Spencer
August 1982, Life sciences,
J A Rosecrans, and W T Chance, and R M Spencer
February 1979, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!